Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using databases to evaluate therapy.

M A Hlatky1

  • 1Stanford University School of Medicine, CA 94305-5093.

Statistics in Medicine
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Clinical databases can reliably compare therapies when validated prognostic models adjust for patient factors. This approach minimizes bias in observational studies, complementing randomized trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply: proton-pump inhibitor use and the risk of first-time ischemic stroke in the general population.

Journal of internal medicine·2017
Same author

Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.

Journal of internal medicine·2017
Same author

Coronary artery bypass graft type and outcomes in maintenance dialysis.

The Journal of cardiovascular surgery·2013
Same author

Population-wide educational strategies for serum cholesterol reduction are cost-effective.

Evidence-based cardiovascular medicine·2005
Same author

An evaluation of beta-blockers, calcium antagonists, nitrates, and alternative therapies for stable angina.

Evidence report/technology assessment (Summary)·2002
Same author

Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.

Annals of internal medicine·2001
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Area of Science:

  • Cardiovascular Research
  • Health Informatics
  • Biostatistics

Background:

  • Clinical databases are increasingly utilized for research purposes.
  • While descriptive studies are common, using databases for therapy comparison is controversial.
  • Validated prognostic models are key to overcoming limitations in database research.

Purpose of the Study:

  • To assess the feasibility of using clinical databases for therapy comparison.
  • To evaluate the utility of validated prognostic models in observational research.
  • To compare medical versus surgical therapy for coronary artery disease using database analysis.

Main Methods:

  • Developed and applied validated prognostic models using the Duke Cardiovascular Disease Database.
  • Compared predictions from these models with established randomized trial outcomes.

Related Experiment Videos

  • Utilized statistical techniques to minimize bias from non-random treatment assignment.

    • Main Results:

    • Predictions from the Duke Cardiovascular Disease Database models closely aligned with major randomized trials.
    • The study demonstrated successful comparison of medical and surgical therapies.
    • Findings support the validity of using statistical methods on reliable clinical data.

    Conclusions:

    • Validated prognostic models enable reliable therapy comparisons using clinical databases.
    • Observational clinical data analysis, when carefully performed, can effectively complement randomized studies.
    • This methodology offers a valuable tool for advancing clinical research and understanding treatment outcomes.